Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Familiar Principles In Gene Therapy Guidance For Rare Diseases

Jul 12 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Sarepta Should Gain Clean Slate With CBER Review of DMD Gene Therapy

Jun 20 2018

CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

Jun 22 2018

From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program

Jan 09 2018

The Luxturna Model: Spark’s Approach To Retinal Disease Endpoint Embraced In Gene Therapy Guidance

Jul 12 2018

Gene Therapies Need Long-Term Follow-Up Plan From Outset Or Risk Clinical Hold

Jul 12 2018

US FDA's Biologics Center Director Expects It Soon Will See 'Growth Spurt'

Jul 02 2018

Additional Topics

United States Biologics Rare Diseases Regulation FDA Regenerative Medicine BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window